NVMI.NASDAQNova LTD

20-F: Nova Ltd. Reports Record 2025 Growth, Strategic Acquisitions

Sentiment:

Annual Report


Nova Ltd. achieved record product and service sales, profitability, and earnings per share in 2025, driven by strategic acquisitions and diversified metrology solutions.

Capital raiseOn September 5, 2025, closed an offering of $750 million aggregate principal amount of 0% Convertible Senior Notes due 2030 in a private offering to qualified institutional buyers.The funds raised will be utilized for further investment in the company's growth and resiliency to enhance shareholder value.In connection with the 2030 Convertible Senior Notes, the company entered into privately-negotiated capped call transactions, paying an aggregate amount of $51.826 million, which are expected to reduce potential dilution and/or offset cash payments upon conversion.
Better than expectedAchieved record product and service sales, profitability, and earnings per share in 2025.Total revenues increased by 31% in 2025, significantly contributing to overall financial performance.Product sales revenue increased by 31% and service revenue increased by 31% in 2025.Net income increased by 41% in 2025 compared to 2024.Working capital and total cash, deposits, and marketable securities saw substantial increases.Outperformed the Process Control sector's CAGR for product revenues over the past five years (27.5% vs. 16.0%).

Summary

  • Achieved record product and service sales, profitability, and earnings per share in 2025.
  • Demonstrated a diversified customer mix across multiple territories.
  • Expanded into advanced packaging with new and existing products, and saw further market adoption of advanced metrology portfolio including Materials, Chemical, and Dimensional solutions, coupled with hardware, software, machine learning, and AI capabilities.
  • Reported record sales across all product lines: optical integrated and stand-alone systems, materials metrology systems, and chemical metrology systems.
  • Continued significant investments in research and development programs to generate new organic growth engines for process control.
  • Deepened collaboration with research institutes and customer development centers, solidifying its position as a long-term technology development and high-volume manufacturing partner.
  • Published its second Sustainability Insight Review on April 28, 2025, detailing its ESG strategy and principles.
  • Completed the acquisition of Sentronics Metrology GmbH on January 30, 2025, expanding its optical technology base to wafer metrology tools for backend semiconductor fabrication.
  • Closed an offering of $750 million aggregate principal amount of 0% Convertible Senior Notes due 2030 on September 5, 2025, to fund further growth and resiliency investments.
  • Total revenues increased by $208.2 million, or 31%, in 2025 compared to 2024, reaching $880.6 million.
  • Product sales revenue was $705.6 million in 2025, an increase of 31% from 2024.
  • Service revenue was $175.0 million in 2025, an increase of 31% from 2024.
  • Product gross margin was 60% in 2025, a slight decline from 61% in 2024, primarily due to a shift in product and customer volumes mix.
  • Service gross margin increased to 47% in 2025, up from 44% in 2024, due to economies of scale.
  • Net research and development expenses were $143.4 million in 2025, a 30% increase from 2024, representing 16% of revenues.
  • Sales and marketing expenses were $82.2 million in 2025, a 26% increase from 2024, representing 9.3% of revenues.
  • General and administrative expenses were $26.1 million in 2025, an 8% increase from 2024, representing 3.0% of revenues.
  • Operating income was $253.5 million in 2025, representing 29% of total revenues.
  • Net financial income was $49.8 million in 2025, up from $28.7 million in 2024, mainly due to higher interest income and exchange rate impact.
  • Income tax expenses were $44.1 million in 2025, reflecting an effective tax rate of 15%.
  • Net income was $259.2 million in 2025, a 41% increase from $183.8 million in 2024.
  • Basic earnings per share increased to $8.61 in 2025 from $6.31 in 2024.
  • Diluted earnings per share increased to $7.96 in 2025 from $5.75 in 2024.
  • Working capital increased to $1,186 million as of December 31, 2025, from $514 million as of December 31, 2024.
  • Cash, cash equivalents, short-term and long-term deposits, and marketable securities totaled $1,646 million as of December 31, 2025, up from $820 million in 2024.
  • Operating activities generated $245 million in cash flow in 2025, compared to $235 million in 2024.
  • Gross capital expenditures were approximately $33 million in 2025, financed from operating cash flow.
  • Total personnel increased to 1,612 as of December 31, 2025, from 1,383 in 2024.
  • The five largest customers accounted for 51% of total revenues in 2025, with individual contributions ranging from 6% to 23%.
  • Geographically, China accounted for 33% of revenues, Taiwan 29%, Korea 16%, and USA 9% in 2025.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong performance, marked by record financial results, strategic acquisitions, and significant investments in R&D and market expansion, positioning the company well for future growth despite inherent industry risks.

Positives

  • Achieved record product and service sales, profitability, and earnings per share in 2025.
  • Reported strong total revenue growth of 31% in 2025, reaching $880.6 million.
  • Product sales revenue increased by 31% to $705.6 million, and service revenue increased by 31% to $175.0 million in 2025.
  • Improved service gross margin to 47% in 2025, driven by economies of scale.
  • Significantly increased cash reserves and working capital, with total cash, deposits, and marketable securities reaching $1,646 million.
  • Successfully diversified its technology portfolio to include Material and Chemical metrology capabilities, and integrated advanced machine learning and AI algorithms.
  • Completed the strategic acquisition of Sentronics Metrology GmbH, expanding its offerings in the rapidly growing advanced wafer level packaging and specialty devices market.
  • Successfully closed a $750 million offering of 0% Convertible Senior Notes due 2030, strengthening its financial position for future growth and resiliency.
  • Generated strong positive cash flow from operating activities of $245 million in 2025.
  • Maintained effective internal control over financial reporting as of December 31, 2025.
  • Outperformed the Process Control sector's Compound Annual Growth Rate (CAGR) for product revenues over the past five years (27.5% vs. 16.0%).

Negatives

  • Product gross margin slightly declined to 60% in 2025 from 61% in 2024, primarily due to a shift in the product and customer volumes mix.
  • Dependence on a small number of large customers (top 5 accounted for 51% of total revenues in 2025) poses a significant customer concentration risk.
  • Exposure to foreign political and economic risks, particularly in Asia (e.g., growing tensions between Taiwan and China) and the Middle East (e.g., Israel-Hamas conflict), could impede revenue streams.
  • Increased cybersecurity threats, potentially leveraging AI, pose ongoing risks to information systems and data security despite mitigation efforts.
  • The newly implemented ERP system, launched in January 2026, requires ongoing maintenance, monitoring, and enhancements, with potential for inefficiencies until stabilization.
  • Lengthy sales cycles (over 12 months for new customers/products) increase exposure to customer delays in orders, which may result in obsolete inventory and volatile quarterly revenues.
  • Dependence on a limited number of suppliers, and in some cases a sole supplier, creates a risk of supply chain disruption, delay, or termination.
  • Certain commercial agreements with Process Equipment Manufacturers (PEMs) and customers may include exclusivity provisions and limitations on the use of certain intellectual property, potentially restricting future business relationships or product introductions.
  • The 2030 Convertible Senior Notes may impact financial results, dilute existing shareholders upon conversion, and create downward pressure on the price of ordinary shares.
  • Potential for increased Israeli withholding tax gross-up costs if anticipated clarifications from the Israeli Tax Authorities regarding the Convertible Senior Notes are not ultimately obtained.
  • Risk of not having the ability to raise necessary funds to settle conversions of the 2030 Convertible Senior Notes, repurchase them upon a fundamental change, or repay them at maturity if required.
  • Currency fluctuations, particularly the devaluation of the U.S. dollar against the New Israeli Shekel and Euro, could seriously harm profit margins.
  • Participation in government R&D grant programs (e.g., IIA, European programs) imposes restrictions on the ability to use developed technologies and manufacture products outside the funding country, potentially increasing costs or limiting flexibility.
  • The application of tax laws is subject to interpretation, and challenges by tax authorities could result in an increase to the worldwide effective tax rate.
  • Changes in U.S. tax laws, such as the modification to Foreign Derived Deduction Eligible Income (FDDEI) under the OBBBA, could materially and adversely impact the effective tax rate beginning in 2026.
  • Quarterly operating results can fluctuate significantly due to factors like the timing of orders and shipments, making revenue forecasting challenging.
  • Some contracts and arrangements potentially subject the company to significant or non-limited liability for product defects or infringement of third-party intellectual property rights.
  • A large number of ordinary shares (approximately 42%) are cumulatively owned by a relatively small number of shareholders, whose future sales could depress the share price.
  • The company does not expect to pay cash dividends for at least the next several years, as it intends to retain earnings for operations and business growth.

Risks

  • Increased cybersecurity threats and more sophisticated computer crime could disrupt business, including potential leveraging of AI for cyberattacks.
  • Dependence on international sales exposes the company to foreign political and economic risks, including inflation, recession, foreign currency exchange restrictions, and military/political conflicts (e.g., Russia-Ukraine war, Taiwan-China tensions, Israel-Hamas conflict).
  • Subject to laws and regulations that could restrict operations, including economic sanctions and export restrictions (e.g., U.S. Department of Commerce restrictions on Chinese semiconductor manufacturers, advanced technology nodes, and high-power advanced chips).
  • Changes in global trade policies, tariffs, and other factors beyond control may adversely impact business, financial condition, and results of operations.
  • Changes in U.S. taxation of international business activities or adoption of other tax reform policies (e.g., OBBBA's FDDEI changes, OECD Pillar Two global minimum tax) could materially impact business, results, or financial condition.
  • Instability in the global economy and financial turmoil, including current market conditions, inflation, and recessionary pressures, could affect growth and profitability.
  • Inability to protect intellectual property (patents, trade secrets) could harm competitive position, especially with expiring patents and less protection under foreign law.
  • Significant litigation involving intellectual property rights in the semiconductor and related industries could force diversion of resources or deter customers.
  • Incorporation of open-source technology in software and products may expose the company to liability or require disclosure of proprietary source code.
  • Use of AI technologies may expose the company to liability (e.g., accuracy, quality, legal/commercial terms, security, IP infringement) and competitors may be more successful in integrating AI.
  • Operating in an extremely competitive market (e.g., Onto Innovation Inc., KLA Corp., ASML Holdings N.V., LAM Research, Applied Materials Inc., Merck, Camtek) means failure to compete effectively could lead to declining revenues and market share.
  • Failure to respond effectively and on a timely basis to rapid technological changes could diminish ability to attract and retain customers.
  • Ongoing consolidation in the industry may harm the company if competitors offer a broader range of products and greater customer support or if main suppliers are acquired.
  • Target markets are cyclical, making it difficult to predict the length and strength of any downturn or expansion period.
  • Operations may be delayed or interrupted, and business could suffer if environmental, safety, and health (ESH) regulations are violated.
  • Challenges relating to the implementation and ongoing operation of the new ERP system could negatively impact business and operations.
  • Dependence on few specific product lines means factors adversely affecting pricing and demand for these lines could substantially reduce sales.
  • Dependence on a small number of large customers (51% from top 5 in 2025) means the loss of one or more could significantly lower revenues.
  • Inability to significantly reduce spending during a protracted slowdown in the semiconductor industry could reduce prospects of achieving continued profitability.
  • No assurance that revenues from future products or product enhancements will be sufficient to recover development costs or ensure the sale of inventory.
  • New product lines introduced in the future may contain defects, requiring allocation of time and financial resources to correct.
  • Failure of any systems to meet or exceed internal quality specifications could delay shipments and adversely affect business and reputation.
  • Dependence on a single manufacturing facility per product line magnifies the risk of an interruption in production capabilities.
  • Lease agreements for Manufacturing Facilities include provisions that exempt landlords from liability for damages, potentially leading to substantial unrecovered costs.
  • Shipment changes or cancellations may render backlog an unreliable indicator of actual sales and financial results.
  • May not be successful in efforts to complete and integrate current and/or future acquisitions, which could disrupt current business activities.
  • Dependence on continuous cooperation with Process Equipment Manufacturers (PEMs) to enable sales of integrated systems; loss of PEM partners could harm business.
  • Some commercial agreements with PEMs and customers may include exclusivity provisions and limitations on the use of certain intellectual property, restricting future business relationships.
  • Dependence on a limited number of suppliers, and in some cases a sole supplier, creates disruption risk.
  • Disclosure rules regarding the use of conflict minerals may affect relationships with suppliers and customers.
  • Lengthy sales cycle increases exposure to customer delays in orders, which may result in obsolete inventory and volatile quarterly revenues.
  • Inability to attract, recruit, retain, and develop highly skilled key personnel due to intense competition.
  • Conditions in Israel, including conflicts with certain parties in the region, as well as political and economic instability, may adversely affect business, results of operations, and ability to raise additional funds.
  • 2030 Convertible Senior Notes may impact financial results, dilute existing shareholders, create downward pressure on the price of ordinary shares, and restrict ability to take advantage of future opportunities.
  • Capped call transactions may affect the value of debt and ordinary shares.
  • Currency fluctuations could harm profit margins, especially with a significant portion of expenses incurred in New Israeli Shekels and Euro.
  • Receipt of research and development grants could impose restrictions on the ability to use technology developed under these programs, and reduction or termination would increase costs.
  • Application of tax laws is subject to interpretation, and challenges by tax authorities could result in an increase to the worldwide effective tax rate.
  • Enactment of legislation implementing changes in taxation of international business activities, adoption of other corporate tax reform policies, or changes in tax legislation (e.g., OBBBA, OECD BEPS Pillar Two) could impact future financial position and results of operations.
  • Changes in certain tax benefits under the Israeli Capital Investment Encouragement Law may increase the effective tax rate.
  • Quarterly fluctuations in operating results may adversely impact share price.
  • Some contracts and arrangements potentially subject the company to the risk of significant or non-limited liability for product defects or intellectual property infringement.
  • A large number of ordinary shares continue to be owned by a relatively small number of shareholders (42% by six shareholders), whose future sales could depress the share price.
  • Certain shareholders may control the outcome of matters submitted to a vote of shareholders, including the election of directors.
  • The market price of ordinary shares may be affected by a limited trading volume and may fluctuate significantly.
  • Management of available cash through various bank institutions and investment of large portions of cash reserves in bank deposits carries the risk that bankruptcy of a bank could prevent access to cash.
  • Investment portfolio may be adversely affected by market conditions and interest rates.
  • Failure to maintain effective internal control over financial reporting could result in investigation or sanctions by regulatory authorities and adversely affect operating results and investor confidence.
  • Risks associated with third-party distributors and agents, including challenges in enforcing contracts, collecting accounts receivable, and ensuring compliance with laws.
  • Provisions of Amended and Restated Articles of Association and Israeli law may delay, prevent, or make difficult an acquisition of Nova.
  • The rights and responsibilities of shareholders are governed by Israeli law and differ in some respects from those under U.S. law.
  • Difficulty asserting a claim under U.S. securities laws or enforcing a U.S. judgment against the company or its officers, directors, or Israeli auditors.
  • Shares listed for trade on more than one stock exchange (Nasdaq and TASE) may result in price variations.
  • Business could be negatively affected as a result of actions of activist shareholders.
  • May be classified as a passive foreign investment company (PFIC) for U.S. income tax purposes, which could have significant and adverse tax consequences to U.S. shareholders.
  • As a foreign private issuer, subject to reporting and corporate governance requirements that differ from U.S. domestic companies; loss of this status could result in significant additional costs and expenses.

Future Outlook

The company plans to focus on investing in organizational development to enhance human capital, strengthening its competitive market position through unique innovation and technological leadership, and executing its strategy to reach $1 billion USD in revenues by 2027. It aims to expand total available markets by addressing new emerging metrology applications and market sectors, including advanced Logic technology nodes, memory scaled 3D-NAND nodes, DRAM scaled devices, and advanced packaging schemes. The company will continue delivering metrology systems for mature technology nodes, fostering collaborations and joint research programs, and diversifying products through new introductions. Strategic initiatives include creating synergy between product lines for combined offerings, growing production facilities and offices footprint, building an extensive roadmap for Sentronics products, and successfully completing the go-live and stabilization of its new ERP system. The company also intends to continue seeking investment opportunities to broaden its portfolio and enrich its brand.

Management Comments

  • "We are determined as a company to play a vital role in creating a world that values equality, safety and environmental health for the benefit of future generations to come."
  • "We remain committed to proactively invest in embedding social responsibility and sustainability as part of our culture and business management to support our values."
  • "It is our belief that we have been able to consistently improve our market position because of a combination of factors: Optical metrology has become an enabler for the industry over the last few years. Materials metrology has been widely adopted by leading memory and logic/foundry customers. We expect further adoption in the next few years. The growing adoption of our metrology portfolio in the advanced packaging market. The growing need for chemical process control and replenishment solutions, driven by ESG and environment sustainability trends for reduction in chemical materials waste. Our unique metrology portfolio, combining optical, X-Ray and chemical metrology for both dimensions and materials. This provides the most advanced portfolio, combining the best innovative metrology capabilities with the best reliability and return on investment. The ability to provide a unique and differentiated technology portfolio sets us apart from the competition and adds a competitive edge to our offering. Our solutions are well accepted by leading customers that allow us to gain more market share with additional process steps and new applications. Our ability to closely team with our customers allows us to predict the industry evolution and process control challenges and by that introduce innovative metrology roadmap to solve industry needs. Our diversified portfolio, which is a result of continuous investment in research and development, is becoming more attractive to our customers. Extending our solutions base to include hardware and software elements in a coupled offering. Successful track record in completing and integrating inorganic products, as a result of M&A, which allows us to diversify our product offering to expand our addressable markets. Well controlled and efficient operating model to support our profitable growth and operational resiliency."
  • "We anticipate ongoing growth in the adoption of our solutions as the semiconductor manufacturing process becomes increasingly complex and the industry evolves."
  • "We believe that our target market is growing as we expand our offering to more stages of the semiconductor manufacturing process and develop innovative new metrology solutions."
  • "As the semiconductor production process becomes increasingly challenging, we believe that the need for our diverse portfolio of technologies for dimensional, materials and chemical metrology will continue to grow in the coming years."

Industry Context

StockSavvy.ai notes that Nova's record growth in 2025 aligns with broader industry trends of increasing demand for semiconductors, driven by AI, data centers, IoT, automotive, and green energy solutions. The growing complexity of chip design and manufacturing, including the transition to 3D devices and advanced packaging, creates a strong demand for advanced metrology and process control solutions, which Nova is actively addressing through its diversified portfolio and strategic acquisitions like Sentronics. The company's focus on materials and chemical metrology also positions it well within the industry's shift towards novel materials and tighter environmental regulations. Gartner forecasts of 33% semiconductor revenue growth and 12% WFE growth in 2026 suggest a favorable market environment for Nova's continued expansion.

Comparison to Industry Standards

  • Nova's 5-year (2020-2025) Compound Annual Growth Rate (CAGR) of products revenues was approximately 27.5%, significantly outperforming Gartner Inc.'s estimate of 16.0% CAGR for the Process Control sector during the same period.
  • Nova competes mainly with Onto Innovation Inc. and KLA Corp. in CD, thin films, and chemical metrology and process control systems.
  • In the wafer level packaging and specialty markets, following the Sentronics acquisition, Nova is in direct competition with companies such as Merck and Camtek.
  • Nova also competes with process equipment manufacturers like ASML Holdings N.V., LAM Research, and Applied Materials Inc., which develop (or may acquire companies which develop) in-situ sensors and metrology products.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chairman of the Board of DirectorsN/A (served as member of board since Oct 2019, President and CEO until March 31, 2023)Eitan OppenhaimMarch 31, 2023Appointed Chairman after serving as President and CEO.
President & Chief Executive OfficerEitan OppenhaimGabriel WaismanMarch 31, 2023Appointed CEO after serving as Chief Business Officer (CBO).
DirectorN/AYaniv GartyApril 2, 2023Appointed by the board of directors.
General Manager Chemical Metrology Division and Managing Director of German subsidiaryN/ADr. Thomas SchĂĽttApril 2023Appointed to lead the Chemical Metrology Division and German subsidiary.
Chief Financial OfficerN/A (implied previous CFO)Guy KiznerJuly 1, 2024Promoted from Director of Financial Planning & Analysis and Vice President of Corporate Finance.
DirectorN/ARami HadarDecember 24, 2025Appointed by the board of directors.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Board CompositionThe board of directors currently consists of seven directors, including two female directors.N/A (as of February 5, 2026)Enhances diversity on the board.
Committee ResponsibilitiesThe Nominating Governance and Sustainability Committee's responsibilities were expanded to include recommending on governance matters, developing business conduct and ethics guidelines, and overseeing the company's policies, programs, and strategies related to environmental, social, and governance (ESG) matters.June 2022Strengthens the company's focus on corporate governance and ESG matters, aligning with evolving stakeholder expectations.
New Committee EstablishmentA Strategy and M&A Committee was established to provide recommendations on the company's strategy, strategic plans, and the identification and analysis of acquisition, merger, joint venture, and investment opportunities.August 2023Formalizes and enhances strategic planning and oversight of M&A activities, potentially leading to more effective growth initiatives.
Compensation Policy ApprovalShareholders approved the current compensation policy for executive officers and directors.June 18, 2025Ensures compensation practices align with shareholder interests and regulatory requirements, promoting long-term retention and motivation.
Clawback Policy AdoptionA clawback policy was adopted, as contemplated by SEC and Nasdaq rules, requiring the recovery of erroneously awarded compensation.October 2, 2023Increases accountability for executive compensation based on accurate financial performance.
Director and Officer ExculpationShareholders approved the exemption of directors and officers in advance for all or any of their liability for damage in consequence of a breach of the duty of care vis-a-vis the company, to the fullest extent permitted by applicable law.June 18, 2025Provides legal protection to directors and officers, potentially aiding in attracting and retaining talent, but may reduce accountability in certain circumstances.
Insider Trading Policy UpdateThe insider trading policy was amended to include specific cooling-off periods for Rule 10b5-1 trading plans for directors, officers, and employees, and prohibits certain transactions like short sales and hedging.February 11, 2026 (amended date)Enhances compliance with insider trading regulations and reduces the appearance of impropriety, fostering investor confidence.
Section 16(a) ReportingDirectors and certain officers will become subject to Section 16(a) reporting requirements of the Exchange Act.March 18, 2026Increases transparency of insider transactions for these individuals, aligning with U.S. domestic issuer standards.

Legal Proceedings

  • Not currently involved in any significant legal proceedings or claims that are expected to have a material effect on consolidated financial position, results of operations, or cash flows.

Related Party Transactions

  • Obtained directors and officers liability insurance in November 2025 with aggregate coverage of $85 million (including $20 million Side A DIC), approved by the compensation committee in accordance with the compensation policy.
  • Undertook to indemnify officers and directors up to the greater of 25% of the company's total shareholders' equity, $200 million, 10% of total market cap, or the aggregate proceeds from a public offering, as approved by shareholders on June 24, 2021.
  • Shareholders approved on June 18, 2025, the exemption of directors and officers in advance for all or any of their liability for damage in consequence of a breach of the duty of care vis-a-vis the company, to the extent permitted by applicable law.
  • Compensation arrangements with directors and executive officers are detailed in Item 6B of the annual report.

Stakeholder Impact

  • **Shareholders**: Potential for dilution from the 2030 Convertible Senior Notes, but also enhanced shareholder value from the company's strong growth strategy and financial performance. The share repurchase program aims to return value to shareholders. Major shareholders hold significant voting power, potentially influencing corporate actions. Activist shareholder actions could impact stock price volatility.
  • **Employees**: The company's focus on organizational development and human capital aims to enhance employee well-being and retention. However, intense competition for high-skilled employees and the impact of Israeli conflicts on reserve duty could affect workforce stability and operational continuity.
  • **Customers**: Benefit from enhanced product offerings and support through continuous R&D and strategic acquisitions like Sentronics. Risks include potential delays in orders due to lengthy sales cycles and the company's dependence on a small number of large customers.
  • **Suppliers**: Face risks from the company's dependence on a limited number of suppliers, and in some cases a sole supplier, which could lead to supply chain disruptions. Compliance with conflict mineral disclosure rules may also affect supplier relationships.
  • **Creditors**: The issuance of $750 million in 0% Convertible Senior Notes due 2030 impacts the company's debt structure. The ability to repay or convert these notes depends on future financial performance and liquidity.

Next Steps

  • Investing in organizational development to enhance human capital and the strength of global teams.
  • Continue to strengthen competitive market position through unique innovation and technological leadership.
  • Continue executing the well-defined strategy to reach $1 billion USD in revenues by 2027.
  • Expand total available markets by addressing new emerging metrology applications and market sectors.
  • Continue delivering metrology systems for mature technology nodes and traditional packaging.
  • Continue collaborations and joint research programs with leading semiconductor manufacturers and research institutes.
  • Continue innovation and diversification of products through new product introductions.
  • Create synergy between product lines towards a combined offering for advanced applications.
  • Grow production facilities and offices footprint to meet semiconductor demand and strategic plans.
  • Continue to develop modern and streamlined core business processes through new ERP and Service CRM infrastructure.
  • Build an extensive roadmap for Sentronics products to broaden the portfolio and cater to additional applications.
  • Create synergy between Nova and Sentronics technologies towards a combined and enhanced offering for advanced packaging applications.
  • Successfully completing the go-live and stabilization of the new ERP system.
  • Continue looking for investment opportunities to broaden the portfolio and enrich the brand.
  • Complete the expansion of the cleanroom in Fremont, CA, U.S., doubling the amount of production bays, during the first half of 2026.
  • Re-evaluate foreign private issuer qualification on June 30, 2026.
  • Directors and certain officers will become subject to Section 16(a) reporting requirements effective March 18, 2026.

Key Dates

DateDescription
May 1993Nova Ltd. was incorporated under the laws of the State of Israel.
October 1993Commenced operations to design, develop, and produce integrated process control systems for semiconductor manufacturing.
April 2000Conducted an initial public offering and shares were listed for trading on the Nasdaq Stock Exchange.
June 2002Listed shares on the Tel Aviv Stock Exchange Ltd. (TASE).
July 31, 2013Eitan Oppenhaim began serving as the President and Chief Executive Officer of the Company.
February 2014Mr. Raanan Cohen was appointed as a director of the Company by the board of directors.
June 2014Ms. Zehava Simon was elected as the Company's external director.
April 2015Acquired ReVera Inc., a privately held company specializing in stand-alone metrology tools.
August 2016Entered into a royalty buyout arrangement with the Israel Innovation Authority (IIA).
September 2016Paid approximately $12.9 million to the IIA as part of the royalty buyout arrangement.
January 1, 2017The 2017 Amendment to the Investments Law, providing new tax benefits for Technology Enterprises, became effective.
December 31, 2017ReVera Inc. merged into its parent company, Nova Measuring Instruments, Inc.
May 2018Elected to opt out from the Israeli Companies Law requirements to appoint external directors and related rules.
June 2022Board of directors expanded the responsibilities of the Nominating Governance and Sustainability Committee.
August 2023Board of directors established the Strategy and M&A Committee.
October 2, 2023Adopted a clawback policy as contemplated by the Clawback Listing Rules.
October 7, 2023Hamas attacks in Israel's southern border, leading to Israel declaring war against Hamas.
July 1, 2024Mr. Guy Kizner began serving as the Chief Financial Officer.
July 12, 2024The European Union's Artificial Intelligence Act (EU AI Act) was published in the EU Official Journal.
August 1, 2024The EU AI Act entered into force.
December 15, 2024ASU No. 2023-09, Income Taxes (Topic 740) Improvements to Income Tax Disclosure, is required to be adopted for fiscal years beginning after this date.
January 1, 2025The Law for the Taxation of Multinational Enterprise Groups – 2025, implementing key aspects of the OECD's Pillar II framework, entered into force in Israel.
January 2025Launched new enterprise resource planning (ERP) system.
January 30, 2025Completed the acquisition of Sentronics Metrology GmbH.
February 2, 2025Provisions regulating prohibited AI practices and AI literacy under the EU AI Act came into effect.
April 2025Paid a bonus of 12 monthly salaries to Mr. Waisman for the acquisition of Sentronics.
April 28, 2025Published its second Sustainability Insight Review.
June 18, 2025Shareholders approved the current compensation policy for executive officers and directors.
July 1, 2025Mr. Waisman was granted an additional 6,710 restricted share units and 6,710 performance-based restricted units.
July 4, 2025The One Big Beautiful Bill Act (OBBBA) was signed into law in the U.S.
August 2, 2025Provisions pertaining to General Purpose AI Models under the EU AI Act came into effect.
August 6, 2025FMR LLC filed Amendment no. 5 to Schedule 13G/A regarding holdings as of June 30, 2025.
September 2, 2025Last reported sale price of the Company's ordinary shares was $237.16.
September 5, 2025Closed an offering of $750 million aggregate principal amount of 0% Convertible Senior Notes due 2030.
September 2025The EU Data Act, adopted on November 27, 2023, had most obligations take effect.
October 2025A ceasefire agreement was reached between Israel and Hamas.
October 15, 2025Maturity date for the 2025 Convertible Senior Notes.
October 17, 2025BlackRock, Inc. filed Schedule 13G regarding holdings as of September 30, 2025.
November 2025Obtained directors and officers liability insurance.
November 10, 2025The 'Affiliates Rule' was suspended for one year, set to terminate on November 9, 2026.
November 13, 2025Migdal Insurance & Financial Holdings Ltd. filed Schedule 13G regarding holdings as of September 30, 2025.
November 19, 2025Applied for a tax ruling from the Israeli Tax Authority (ITA) regarding Israeli withholding tax treatment in connection with the Convertible Senior Notes.
November 2025The European Commission's Digital Omnibus Proposal was published.
December 2025Gartner Q4-2025 forecast for semiconductor revenues and Wafer Fab Equipment (WFE) growth was published.
December 2025The FASB issued ASU No. 2023-09, Income Taxes (Topic 740) Improvements to Income Tax Disclosure.
December 2025The FASB issued ASU 2025-10, Accounting for Government Grants Received by Business Entities.
December 2025The FASB issued ASU 2025-11, Interim Reporting, Narrow-Scope Improvements.
December 2025BIS issued a package of rules designed to further impair China's capability to produce advanced-node semiconductors.
December 2025The Parent Company received final tax assessments for the years 2020-2024 from the Israeli Tax Authorities.
December 24, 2025Mr. Rami Hadar was appointed to serve as a director of the Company.
December 31, 2025End of the fiscal year covered by the annual report.
January 5, 2026The Side-by-Side Package was released, describing a system for OECD Pillar Two global minimum tax provisions.
February 5, 2026Date as of which information on share ownership by directors and senior management was provided.
February 9, 2026Harel Insurance Investments & Financial Services Ltd. filed Amendment no. 12 Schedule 13G/A regarding holdings as of February 5, 2026.
February 11, 2026Insider Trading Compliance Policy was amended.
February 17, 2026Date of the audit report and the signing of the annual report.
March 18, 2026Section 16(a) reporting requirements for directors and certain officers become effective.
First half of 2026Expected completion of the expansion of the cleanroom in Fremont, CA, U.S., doubling production bays.
June 30, 2026The company will re-evaluate its qualification as a foreign private issuer.
November 9, 2026Suspension of the 'Affiliates Rule' is set to terminate.
December 15, 2026ASU No. 2024-03, Income Statement Reporting Comprehensive Income Expense Disaggregation Disclosures, is effective for fiscal years beginning after this date.
January 1, 2027Construction for the Advanced Manufacturing Investment Credit (AMIC) must begin before this date.
2027Company plans to focus on executing its strategy to reach $1 billion USD in revenues.
December 15, 2027ASU 2025-06, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40), is effective for fiscal years beginning after this date.
December 15, 2027Interim periods within fiscal years beginning after this date are subject to ASU No. 2024-03.
September 20, 2028Earliest date the Company may redeem for cash all or any portion of the 2030 Convertible Senior Notes (except in the event of certain tax law changes).
December 15, 2028ASU 2025-10, Accounting for Government Grants Received by Business Entities, is effective for fiscal years beginning after this date.
August 2029Expiration date for the Rehovot lease agreement, with an option to extend for two periods of five years each.
July 2029Expected end date for the Ness Ziona lease.
June 15, 2030Date from which a holder may convert 2030 Convertible Notes at any time, regardless of other circumstances.
September 15, 2030Maturity date for the 2030 Convertible Senior Notes.
August 2034Expiration date for the Fremont, CA lease agreement, with an option to extend for an additional five years.

Recommendation

strong buy

Nova Ltd. has demonstrated exceptional financial performance in 2025, achieving record revenues, profitability, and EPS, significantly outpacing the broader process control sector's growth. The company's strategic acquisitions, particularly Sentronics, and continuous investment in diversified metrology solutions (optical, materials, chemical, AI/ML) position it strongly in the high-growth semiconductor industry, driven by AI and advanced packaging. While risks such as customer concentration, geopolitical instability, and ERP implementation challenges exist, the robust financial health, clear growth strategy to reach $1B in revenues by 2027, and strong R&D pipeline suggest substantial upside potential. The recent $750 million convertible notes offering further strengthens its capital for future expansion.

Keywords

Semiconductor metrology, Process control, Advanced packaging, AI, Machine learning, Optical metrology, X-ray metrology, SIMS, Chemical metrology, Wafer fab equipment, Integrated circuits, R&D, Capital equipment, Israel, Nasdaq, 20-F

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.